Tucotuzumab celmoleukin
Jump to navigation
Jump to search
Template:Short description Template:Drugbox
Tucotuzumab celmoleukin is an anti-cancer drug. It is a fusion protein of a humanized monoclonal antibody (tucotuzumab) and an interleukin-2 (celmoleukin).[1][2][3]
This drug was developed by EMD Pharmaceuticals.
References
<templatestyles src="Reflist/styles.css" />
- ↑ Statement On A Nonproprietary Name Adopted By The Usan Council - Tucotuzumab Celmoleukin, American Medical Association.
- ↑ Clinical trial number NCT00016237 at ClinicalTrials.gov
- ↑ Script error: No such module "citation/CS1".
Script error: No such module "Check for unknown parameters".
Template:Monoclonals for tumors Template:Interleukin receptor modulators